2nd Annual Bradley Z. Naifeh Amyloidosis Conference - Medical Professional Conference - March 1, 2024 - FREE (NO CE CREDIT)
NOTE - CE CREDIT IS NOT AVAILABLE FOR THE FREE SESSION. LEARNERS WISHING TO RECEIVE CE CREDIT MUST REGISTER FOR THE CE CREDIT OFFERING OF THIS ACTIVITY.
Virtual attendance option only
Houston Methodist J.C. Walter Educational Series
Amyloidosis is an underrecognized condition because it has historically been misconceived to be a rare disease and presents in a myriad of clinical situations in a subtle manner. Recent advances in therapeutics have made it imperative that this condition is recognized and categorized appropriately in a timely manner so that individuals can get access to appropriate care. Due to a systemic nature of amyloid, various subspecialities are on the fore front of battling this disease. The goal of the Conference is to create a faculty panel from various disciplines to engage in the mission to promote awareness and educate attendees on Amyloidosis in a comprehensive manner.
Target Audience
Cardiologists, hematologists, neurologists, nephrologists, pulmonologists, hepatologists, nurse practitioners, nurses, social workers, transplant coordinators, and trainees in these subspecialities.
Learning Objectives
Upon completion of this course, the participant should be able to:
- Discuss the two major kinds (AL and TTR) of amyloidosis and appropriate diagnosis and categorization of these kinds.
- Identify how to investigate the various organ involvement in Amyloidosis.
- Discuss the current approved therapies for the two major kinds of amyloidosis (AL and TTR).
- Describe the potential future therapies for both TTR and AL amyloidosis.
Virtual